Group
Companies
History
Business model
Mission and vision
Corporate values
Commitment to sport
Research
Pharmaceutical Research
Sucrosomial Technology
Cetylated Fatty Acids
Quality and certifications
Brands
PharmaNutra
Junia Pharma
Alesco
Akern
Investor
INVESTOR RELATIONS
Stock performance
Share capital and Shareholders
Shares study and research
Broker
Financial statements
Presentations
Corporate events
Company presentation
Notice of meetings
SDIR
AIM admission document
MTA prospectus
PRESS
Press releases
Press review
Governance
Code of Ethics
231 Model
Board of Directors and Committees
Company documents
Internal dealing
Shareholders’ meeting
Statutory auditors and Audit firm
Sharholders Agreements
Sustainability
News
Science
Corporate
Events
Social commitment
Careers
Work with us
Job offers
Job application
Group
Companies
History
Business model
Mission and vision
Corporate values
Commitment to sport
Research
Pharmaceutical Research
Sucrosomial Technology
Cetylated Fatty Acids
Quality and certifications
Brands
PharmaNutra
Junia Pharma
Alesco
Akern
Investor
INVESTOR RELATIONS
Stock performance
Share capital and Shareholders
Shares study and research
Broker
Financial statements
Presentations
Corporate events
Company presentation
Notice of meetings
SDIR
AIM admission document
MTA prospectus
PRESS
Press releases
Press review
Governance
Code of Ethics
231 Model
Board of Directors and Committees
Company documents
Internal dealing
Shareholders’ meeting
Statutory auditors and Audit firm
Sharholders Agreements
Sustainability
News
Science
Corporate
Events
Social commitment
Careers
Work with us
Job offers
Job application
it
en
17 June 2022
GOLDEN POWER NOTIFICATION FILED IN CONNECTION WITH THE ACQUISITION OF 100% OF AKERN S.R.L.
15 June 2022
SIGNING OF THE AGREEMENT FOR THE ACQUISITION OF 100% OF AKERN S.R.L.
08 June 2022
BUY-BACK REPORT MAY 2022
27 May 2022
PUBLICATION OF THE SHAREHOLDERS’ MEETINGS MINUTES HELD ON 27/04/2022
16 May 2022
PHARMANUTRA S.P.A.: INITIATION OF SHARE BUY-BACK PROGRAM
12 May 2022
INTERIM FINANCIAL REPORT AS OF 31 MARCH 2022 NOW AVAILABLE
09 May 2022
PHARMANUTRA S.P.A.: INTERIM REPORT AS AT 31 MARCH 2022
02 May 2022
SYNTHETIC REPORT ON VOTING RESULTS OF THE SHAREHOLDERS’ MEETINGS 27/04/2022
27 April 2022
RESOLUTIONS OF THE SHAREHOLDERS’ MEETING OF 27/04/2022
11 April 2022
BUY-BACK REPORT MARCH 2022
31 March 2022
NOTICE OF PUBLICATIONOF THE 2021 ANNUAL FINANCIAL REPORT
18 March 2022
PHARMANUTRA S.P.A.: FILING OF DOCUMENTS FOR THE SHAREHOLDERS’ MEETING
<
1
…
3
4
5
…
18
>